# OnCo record gtx (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gtx/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gtx" ;
  schema:name "GTx"@en ;
  schema:alternateName "GTx Incorporated"@en, "GTx, Inc."@en ;
  schema:description "GTx was a Memphis biotech that developed selective androgen receptor modulators, including enobosarm for cancer-related muscle wasting and breast cancer, before merging with Oncternal Therapeutics in 2019."@en ;
  schema:url <https://onco.cc/companies/gtx/>, <http://www.gtxinc.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <http://www.gtxinc.com>, <https://clinicaltrials.gov/search?lead=GTx%20Incorporated>, <https://www.wikidata.org/wiki/Q5514784>, <https://en.wikipedia.org/wiki/GTx,_Inc.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:drugs <https://onco.cc/drugs/toremifene/> .